CN109946393B - A kind of method for detecting ciprofloxacin residues in livestock and poultry - Google Patents
A kind of method for detecting ciprofloxacin residues in livestock and poultry Download PDFInfo
- Publication number
- CN109946393B CN109946393B CN201910169867.2A CN201910169867A CN109946393B CN 109946393 B CN109946393 B CN 109946393B CN 201910169867 A CN201910169867 A CN 201910169867A CN 109946393 B CN109946393 B CN 109946393B
- Authority
- CN
- China
- Prior art keywords
- sample
- ciprofloxacin
- solution
- livestock
- poultry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical group C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title claims abstract description 80
- 229960003405 ciprofloxacin Drugs 0.000 title claims abstract description 40
- 244000144972 livestock Species 0.000 title claims abstract description 27
- 244000144977 poultry Species 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 19
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims abstract description 18
- 241001465754 Metazoa Species 0.000 claims abstract description 12
- 238000000605 extraction Methods 0.000 claims abstract description 9
- 239000000523 sample Substances 0.000 claims description 21
- 239000012488 sample solution Substances 0.000 claims description 20
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 13
- 239000012086 standard solution Substances 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000005416 organic matter Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 230000005284 excitation Effects 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000007664 blowing Methods 0.000 claims description 2
- 238000010586 diagram Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 238000001514 detection method Methods 0.000 abstract description 13
- 230000006378 damage Effects 0.000 abstract description 5
- 239000011159 matrix material Substances 0.000 abstract description 5
- 210000003608 fece Anatomy 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052791 calcium Inorganic materials 0.000 abstract description 2
- 239000011575 calcium Substances 0.000 abstract description 2
- 239000002244 precipitate Substances 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 238000007781 pre-processing Methods 0.000 abstract 1
- 235000013594 poultry meat Nutrition 0.000 description 17
- 241000287828 Gallus gallus Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000003746 feather Anatomy 0.000 description 3
- 235000013613 poultry product Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
本发明涉及兽残检测技术领域,公开了一种检测畜禽体内环丙沙星残留的方法,包括样品的预处理和HPLC分析,本发明以畜禽毛发为样品,取样方便,无任何破坏性,不会引起动物的任何伤害和疼痛,易于贮存,与以宰杀后动物的组织或动物的粪便为样本相比,本发明以畜禽毛发为样品的基质干扰影响小,并无需进一步提纯,操作简单,缩短了检测周期,降低了前期处理的工作量和投入成本;选用三氟乙酸酸化甲醇作为提取液,一方面提高了提取效率,另一方面,还可以沉淀畜禽毛发中的钙质,降低基质干扰,有效提高检测结果的准确性。
The invention relates to the technical field of animal residue detection, and discloses a method for detecting ciprofloxacin residues in livestock and poultry, including sample pretreatment and HPLC analysis. , it will not cause any harm and pain to animals, and is easy to store. Compared with the tissue of slaughtered animals or the feces of animals, the matrix of the present invention taking the hair of livestock and poultry as the sample has little interference effect, and no further purification is required. It is simple, shortens the detection period, and reduces the workload and input cost of pre-processing; the use of trifluoroacetic acid acidified methanol as the extraction solution improves the extraction efficiency on the one hand, and on the other hand, it can also precipitate calcium in the hair of livestock and poultry. Reduce matrix interference and effectively improve the accuracy of detection results.
Description
技术领域technical field
本发明涉及兽残检测技术领域,具体涉及一种检测畜禽体内环丙沙星残留的方法。The invention relates to the technical field of animal residue detection, in particular to a method for detecting ciprofloxacin residues in livestock and poultry.
背景技术Background technique
喹诺酮类药物(quinolone)是一类较新的广谱抗菌药,由于其抗菌力强、口服吸收好,与其他抗菌药物无交叉耐药性,已经成为治疗细菌感染性疾病的主要药物。喹诺酮类药物按其发明先后和抗菌性能的不同,分为一、二、三、四代,环丙沙星为第三代喹诺酮类药物,具有抗菌范围广、抗菌活性大、组织穿透力强等特点,在畜禽产品生产中被广泛应用。但是该类药物存在严重持久性的不良反应,包括肌腱损伤、中枢神经系统紊乱等,也可致癌、致突变、产生过敏反应,长期食用环丙沙星残留的畜禽产品必定会给人体健康造成严重伤害。因此,实现畜禽产品中环丙沙星的快速灵敏检测在保证食品安全方面具有积极意义。Quinolone is a new class of broad-spectrum antibacterial drugs. Because of its strong antibacterial activity, good oral absorption, and no cross-resistance with other antibacterial drugs, it has become the main drug for the treatment of bacterial infectious diseases. Quinolones are classified into first, second, third, and fourth generations according to their invention order and different antibacterial properties. Ciprofloxacin is the third generation quinolone, which has a wide antibacterial range, high antibacterial activity and strong tissue penetration. It is widely used in the production of livestock and poultry products. However, such drugs have serious and persistent adverse reactions, including tendon damage, central nervous system disorders, etc., and can also cause cancer, mutagenesis, and allergic reactions. Long-term consumption of livestock and poultry products with ciprofloxacin residues will definitely cause harm to human health. serious injury. Therefore, realizing the rapid and sensitive detection of ciprofloxacin in livestock and poultry products has positive significance in ensuring food safety.
目前,兽药残留的检测通常是以宰杀后动物的组织如肌肉、肝脏等或动物的粪便为样本,但肌肉或肝脏中蛋白质及脂肪的含量较高,粪便中含有大量的金属离子及其它杂质,影响目标物的提取,进而会导致检测结果的可靠性和稳定性较低,另外,为减少基质效应对色谱分析造成干扰,一般需对提取物进行提纯处理,操作比较复杂,增加了前处理的工作量。At present, the detection of veterinary drug residues usually takes the tissues of slaughtered animals such as muscle, liver, etc. or animal feces as samples, but the protein and fat content in muscle or liver are high, and the feces contain a large amount of metal ions and other impurities. It affects the extraction of the target compound, which will lead to low reliability and stability of the detection results. In addition, in order to reduce the interference of the matrix effect on the chromatographic analysis, it is generally necessary to purify the extract. workload.
发明内容SUMMARY OF THE INVENTION
因此,本发明旨在提供一种可活体取样的畜禽体内环丙沙星残留的检测方法,该方法操作简单、快速灵敏且检测结果的可靠性和稳定性高。Therefore, the present invention aims to provide a method for detecting ciprofloxacin residues in livestock and poultry that can be sampled in vivo, which is simple to operate, rapid and sensitive, and has high reliability and stability of detection results.
为此,本发明提供了一种检测畜禽体内环丙沙星残留的方法,包括样品的预处理和HPLC分析,所述样品的预处理包括如下步骤:To this end, the present invention provides a method for detecting ciprofloxacin residues in livestock and poultry, including the pretreatment and HPLC analysis of the sample, and the pretreatment of the sample includes the following steps:
取洁净干燥的畜禽毛发,加入提取液,于不低于65℃下至少提取24h,取上清液,去除上清液中有机物,得待测样品;Take clean and dry livestock and poultry hair, add extracting solution, extract at least 24 hours at a temperature of not lower than 65 °C, take the supernatant, remove the organic matter in the supernatant, and obtain the sample to be tested;
所述提取液为三氟乙酸酸化甲醇,所述三氟乙酸在甲醇中浓度为0.2mol/L。The extraction solution is acidified methanol with trifluoroacetic acid, and the concentration of the trifluoroacetic acid in methanol is 0.2 mol/L.
进一步地,所述待测样品的制备是在绝氧或限氧环境下进行。Further, the preparation of the sample to be tested is carried out in an anaerobic or oxygen-limited environment.
更进一步地,所述去除上清液中有机物是在35~45℃下进行吹氮处理。Further, the removal of organic matter in the supernatant is performed by nitrogen blowing at 35-45°C.
进一步地,向所述畜禽毛发中加入提取液前还包括如下步骤:Further, the following steps are also included before adding the extract to the hair of the livestock and poultry:
取畜禽脖颈区域的毛发,用纯水洗涤至少3次,剪成4~6mm小段,于40~60℃下烘干,密封待用。Take the hair of the neck area of livestock and poultry, wash it with pure water at least 3 times, cut it into small pieces of 4-6mm, dry it at 40-60°C, and seal it for later use.
进一步地,所述HPLC分析的色谱条件为:Further, the chromatographic conditions of the HPLC analysis are:
色谱柱:C18 250mm×4.6nm,填充剂为十八烷基硅烷键合硅胶,粒径为5μm;Chromatographic column: C18 250mm×4.6nm, the filler is octadecylsilane bonded silica gel, and the particle size is 5μm;
流动相:乙腈-0.05mol/L磷酸溶液(v:v=15:85);Mobile phase: acetonitrile-0.05mol/L phosphoric acid solution (v:v=15:85);
流速:0.8mL/min;Flow rate: 0.8mL/min;
进样量:10μL;Injection volume: 10 μL;
柱温:30℃;Column temperature: 30℃;
检测器:荧光检测器,激发波长为280nm,发射波长为450nm。Detector: Fluorescence detector with excitation wavelength of 280 nm and emission wavelength of 450 nm.
进一步地,进行所述HPLC分析前还包括环丙沙星标准溶液及待测样品溶液的配制,具体包括如下步骤:Further, the preparation of ciprofloxacin standard solution and sample solution to be tested is also included before the HPLC analysis, which specifically includes the following steps:
取环丙沙星标准品,加入所述流动相稀释成至少3种不同浓度的环丙沙星标准溶液;Get ciprofloxacin standard substance, add described mobile phase and dilute into at least 3 kinds of ciprofloxacin standard solutions of different concentrations;
取所述待测样品,加入所述流动相,充分溶解所述待测样品,即得所述待测样品溶液。Take the sample to be tested, add the mobile phase, and fully dissolve the sample to be tested to obtain the sample solution to be tested.
进一步地,所述HPLC分析包括如下步骤:Further, the HPLC analysis comprises the steps:
吸取不同浓度的所述环丙沙星标准溶液10μL注入HPLC分析仪,根据测定结果绘制环丙沙星峰面积-溶液浓度的标准曲线图;Draw 10 μL of the ciprofloxacin standard solution of different concentrations and inject it into the HPLC analyzer, and draw the standard curve diagram of ciprofloxacin peak area-solution concentration according to the measurement result;
吸取所述待测样品溶液10μL注入HPLC分析仪,根据峰面积及所述标准曲线图,计算得到所述待测样品溶液中环丙沙星的含量。Pipette 10 μL of the sample solution to be tested and inject it into the HPLC analyzer, and calculate the content of ciprofloxacin in the sample solution to be tested according to the peak area and the standard curve.
本发明的技术方案,具有如下优点:The technical scheme of the present invention has the following advantages:
1.本发明提供的检测畜禽体内环丙沙星残留的方法,以畜禽毛发为样品,取样方便,无任何破坏性,不会引起动物的任何伤害和疼痛,易于贮存,与以宰杀后动物的组织或动物的粪便为样本相比,本发明以畜禽毛发为样品的基质干扰影响小,并无需进一步提纯,操作简单,缩短了检测周期,降低了前期处理的工作量和投入成本;选用酸化甲醇作为提取液,一方面提高了提取效率,另一方面,还可以沉淀畜禽毛发中的钙质,降低基质干扰,有效提高检测结果的准确性。1. The method for detecting ciprofloxacin residues in livestock and poultry provided by the present invention takes the hair of livestock and poultry as a sample, which is convenient for sampling, has no destructiveness, does not cause any injury and pain of animals, is easy to store, and is used after slaughtering. Compared with animal tissue or animal feces as the sample, the present invention takes the animal hair as the sample, and the matrix interference effect is small, and no further purification is required, the operation is simple, the detection period is shortened, and the workload and input cost of the preliminary treatment are reduced; The use of acidified methanol as the extraction solution improves the extraction efficiency on the one hand, and on the other hand, it can also precipitate calcium in the hair of livestock and poultry, reduce matrix interference, and effectively improve the accuracy of detection results.
2.本发明提供的检测畜禽体内环丙沙星残留的方法,在绝氧或限氧环境下制备所述待测样品,提高了样品的稳定性,有效避免样品变质或被污染的可能性。2. In the method for detecting ciprofloxacin residues in livestock and poultry provided by the present invention, the sample to be tested is prepared in an anaerobic or oxygen-limited environment, which improves the stability of the sample and effectively avoids the possibility of sample deterioration or contamination .
3.本发明提供的检测畜禽体内环丙沙星残留的方法,选用畜禽脖颈区域的毛发为取样对象,环丙沙星的累积量较高,并且高度稳定,具有更长的检测时间窗口,提高了检测结果的可靠性和稳定性。对畜禽毛发进行清洗,有效去除脂质和其它外源性干扰,进一步提高了检测结果的准确性。3. The method for detecting ciprofloxacin residues in livestock and poultry provided by the present invention selects the hair in the neck region of livestock and poultry as the sampling object, and the cumulative amount of ciprofloxacin is high, highly stable, and has a longer detection time window. , which improves the reliability and stability of the detection results. The cleaning of livestock and poultry hair can effectively remove lipids and other exogenous interference, and further improve the accuracy of the detection results.
4.本发明提供的检测畜禽体内环丙沙星残留的方法,通过对流动相及各组分配比、流速、温度等条件进行优化组合,可准确检测畜禽毛发中环丙沙星的残余量,该方法具有操作简单及准确性高等特点,适用于畜禽体内环丙沙星残留的定量分析。4. The method for detecting ciprofloxacin residues in livestock and poultry provided by the present invention can accurately detect the residual amount of ciprofloxacin in livestock and poultry hair by optimizing the combination of conditions such as the mobile phase and the distribution ratio of each component, flow rate, temperature, etc. The method has the characteristics of simple operation and high accuracy, and is suitable for quantitative analysis of ciprofloxacin residues in livestock and poultry.
附图说明Description of drawings
为了更清楚地说明本发明具体实施方式或现有技术中的技术方案,下面将对具体实施方式或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本发明的一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to illustrate the specific embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the specific embodiments or the prior art. Obviously, the accompanying drawings in the following description The drawings are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained based on these drawings without creative efforts.
图1是本发明实施例1中待测样品溶液的HPLC色谱图;Fig. 1 is the HPLC chromatogram of the sample solution to be tested in the embodiment of the
图2是本发明实施例1中加标样品溶液(加标浓度为5μg/mL)的HPLC色谱图。FIG. 2 is the HPLC chromatogram of the spiked sample solution (spike concentration is 5 μg/mL) in Example 1 of the present invention.
具体实施方式Detailed ways
提供下述实施例是为了更好地进一步理解本发明,并不局限于所述最佳实施方式,不对本发明的内容和保护范围构成限制,任何人在本发明的启示下或是将本发明与其他现有技术的特征进行组合而得出的任何与本发明相同或相近似的产品,均落在本发明的保护范围之内。The following examples are provided for a better understanding of the present invention, and are not limited to the best embodiments, and do not limit the content and protection scope of the present invention. Any product identical or similar to the present invention obtained by combining with the features of other prior art shall fall within the protection scope of the present invention.
实施例中未注明具体实验步骤或条件者,按照本领域内的文献所描述的常规实验步骤的操作或条件即可进行。所用试剂或仪器未注明生产厂商者,均为可以通过市购获得的常规试剂产品。If the specific experimental steps or conditions are not indicated in the examples, it can be carried out according to the operations or conditions of the conventional experimental steps described in the literature in this field. The reagents or instruments used without the manufacturer's indication are all conventional reagent products that can be obtained from the market.
实施例1Example 1
本实施例提供了一种检测畜禽体内环丙沙星残留的方法,包括如下步骤:The present embodiment provides a method for detecting ciprofloxacin residues in livestock and poultry, comprising the following steps:
(1)取鸡脖颈区域的毛发,用纯水洗涤3次,剪成4~6mm的小段,在50℃下烘干,装入自封袋中并置于干燥皿中待用。(1) Take the hair of the chicken neck area, wash it three times with pure water, cut it into small pieces of 4-6 mm, dry it at 50°C, put it in a ziplock bag and place it in a drying dish for use.
(2)称取0.15g上述处理过的鸡毛,置于螺旋玻璃厌氧管中,加入10mL三氟乙酸酸化甲醇(三氟乙酸的浓度为0.2mol/L),加热至70℃提取24h,取上清液5mL,40℃氮气条件下吹干,得待测样品。(2) Weigh 0.15 g of the above-treated chicken feathers, place them in a spiral glass anaerobic tube, add 10 mL of trifluoroacetic acid to acidify methanol (the concentration of trifluoroacetic acid is 0.2 mol/L), heat to 70°C for extraction for 24 hours, and take 5 mL of the supernatant was dried under nitrogen at 40°C to obtain the sample to be tested.
(3)配制环丙沙星标准溶液、待测样品溶液及加标样品溶液(3) Preparation of ciprofloxacin standard solution, sample solution to be tested and sample solution for adding standard
称取环丙沙星标准品5.0mg,置于5mL容量瓶内,用流动相(乙腈-0.05mol/L磷酸,v:v=15:85)溶解并定容至刻度线,摇匀得1mg/mL环比沙星储备液。准确吸取上述环丙沙星储备液1mL于10mL容量瓶中,用流动相(乙腈-0.05mol/L磷酸,v:v=15:85)溶解并稀释至刻度线,稀释成浓度为100μg/mL的工作液,再按照上述方法进行稀释,得到浓度为0.05μg/mL、0.1μg/mL、0.5μg/mL、1.0μg/mL、5.0μg/L、10μg/mL及50μg/mL的标准溶液,0℃下避光保存备用;Weigh 5.0 mg of standard ciprofloxacin, put it in a 5 mL volumetric flask, dissolve it with mobile phase (acetonitrile-0.05 mol/L phosphoric acid, v:v=15:85) and dilute to the mark, shake well to get 1 mg /mL cyclopyrifloxacin stock solution. Accurately pipette 1mL of the above ciprofloxacin stock solution into a 10mL volumetric flask, dissolve and dilute to the scale line with mobile phase (acetonitrile-0.05mol/L phosphoric acid, v:v=15:85), and dilute to a concentration of 100μg/mL The working solution was diluted according to the above method to obtain standard solutions with concentrations of 0.05 μg/mL, 0.1 μg/mL, 0.5 μg/mL, 1.0 μg/mL, 5.0 μg/L, 10 μg/mL and 50 μg/mL, Store at 0°C in the dark for future use;
向上述待测样品中加入1mL流动相(乙腈-0.05mol/L磷酸,v:v=15:85),充分溶解,即得所述待测样品溶液;Add 1 mL of mobile phase (acetonitrile-0.05mol/L phosphoric acid, v:v=15:85) to the above-mentioned sample to be tested, and fully dissolve to obtain the sample solution to be tested;
称取0.15g步骤(1)中处理过的鸡毛,加入0.1mL 5μg/mL标准溶液,静置2h,加入10mL三氟乙酸酸化甲醇(三氟乙酸的浓度为0.2mol/L),加热至65℃提取24h,取上清液5mL,40℃氮气条件下吹干,得加标待测样品,加入1mL流动相(乙腈-0.05mol/L磷酸,v:v=15:85),即得所述加标样品溶液。Weigh 0.15g chicken feathers treated in step (1), add 0.1mL 5μg/mL standard solution, let stand for 2h, add 10mL trifluoroacetic acid acidified methanol (the concentration of trifluoroacetic acid is 0.2mol/L), heat to 65 Extraction at ℃ for 24h, take 5 mL of supernatant, dry it under nitrogen at 40 ℃, to obtain the sample to be tested, add 1 mL of mobile phase (acetonitrile-0.05mol/L phosphoric acid, v:v=15:85), that is, the obtained the spiked sample solution.
(4)HPLC分析(4) HPLC analysis
色谱分析条件:色谱柱:C18 250mm×4.6nm,填充剂为十八烷基硅烷键合硅胶为,粒径为5μm;流动相:乙腈-0.05mol/L磷酸溶液(v:v=15:85);流速:0.8mL/min;进样量:10μL;柱温:30℃;检测器:荧光检测器,激发波长为280nm,发射波长为450nm。Chromatographic analysis conditions: chromatographic column: C18 250mm×4.6nm, filler is octadecylsilane bonded silica gel, particle size is 5μm; mobile phase: acetonitrile-0.05mol/L phosphoric acid solution (v:v=15:85 ); flow rate: 0.8 mL/min; injection volume: 10 μL; column temperature: 30 °C; detector: fluorescence detector, excitation wavelength is 280 nm, emission wavelength is 450 nm.
分别吸取0.05μg/mL、0.1μg/mL、0.5μg/mL、1.0μg/mL、5.0μg/L、10μg/mL、50μg/mL及100μg/mL的环丙沙星标准溶液10μL,注入HPLC分析仪,根据测定结果绘制环丙沙星峰面积-溶液浓度的标准曲线图,拟合,求回归方程和相关系数。结果表明,在0.05~100μg/mL浓度范围内,线性关系良好,相关系数均在0.999以上。Pipette 10 μL of ciprofloxacin standard solution of 0.05 μg/mL, 0.1 μg/mL, 0.5 μg/mL, 1.0 μg/mL, 5.0 μg/L, 10 μg/mL, 50 μg/mL and 100 μg/mL respectively, and inject them into HPLC analysis According to the measurement results, draw the standard curve of ciprofloxacin peak area-solution concentration, fit, and find the regression equation and correlation coefficient. The results showed that in the concentration range of 0.05~100μg/mL, the linear relationship was good, and the correlation coefficients were all above 0.999.
吸取待测样品溶液10μL,注入HPLC分析仪,分析图谱见图1,根据环丙沙星峰面积和上述标准曲线图,得到待测样品溶液中环丙沙星的浓度,计算得到鸡毛中环丙沙星的残余量,见下表1。Draw 10 μL of the sample solution to be tested, inject it into the HPLC analyzer, and see Figure 1 for the analysis spectrum. According to the peak area of ciprofloxacin and the above standard curve, the concentration of ciprofloxacin in the sample solution to be tested is obtained, and the ciprofloxacin in chicken feathers is calculated by calculating. The residual amount is shown in Table 1 below.
吸取加标样品溶液10μL,注入HPLC分析仪,分析图谱见图2,根据环丙沙星峰面积和上述标准曲线图,得到加标样品溶液中环丙沙星的浓度,计算得到加标回收率,见下表1。Draw 10 μL of the spiked sample solution and inject it into the HPLC analyzer. The analytical spectrum is shown in Figure 2. According to the ciprofloxacin peak area and the above standard curve graph, the concentration of ciprofloxacin in the spiked sample solution is obtained, and the spiked recovery rate is calculated. See Table 1 below.
表1环丙沙星残余量及加标回收率Table 1 Ciprofloxacin Residual Amount and Standard Recovery Rate
(备注:1为待测样品溶液;2为加标样品溶液)。(Note: 1 is the sample solution to be tested; 2 is the sample solution with added standard).
由上表中的数据可知,本发明的检测方法具有良好的准确性。As can be seen from the data in the above table, the detection method of the present invention has good accuracy.
显然,上述实施例仅仅是为清楚地说明所作的举例,而并非对实施方式的限定。对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无需也无法对所有的实施方式予以穷举。而由此所引伸出的显而易见的变化或变动仍处于本发明创造的保护范围之中。Obviously, the above-mentioned embodiments are only examples for clear description, and are not intended to limit the implementation manner. For those of ordinary skill in the art, changes or modifications in other different forms can also be made on the basis of the above description. There is no need and cannot be exhaustive of all implementations here. And the obvious changes or changes derived from this are still within the protection scope of the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910169867.2A CN109946393B (en) | 2019-03-06 | 2019-03-06 | A kind of method for detecting ciprofloxacin residues in livestock and poultry |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910169867.2A CN109946393B (en) | 2019-03-06 | 2019-03-06 | A kind of method for detecting ciprofloxacin residues in livestock and poultry |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109946393A CN109946393A (en) | 2019-06-28 |
CN109946393B true CN109946393B (en) | 2022-07-22 |
Family
ID=67009219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910169867.2A Active CN109946393B (en) | 2019-03-06 | 2019-03-06 | A kind of method for detecting ciprofloxacin residues in livestock and poultry |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109946393B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2020003136A (en) * | 2013-06-26 | 2021-03-25 | Indigo Ag Inc | Seed-origin endophyte populations, compositions, and methods of use. |
CN109596722A (en) * | 2017-09-30 | 2019-04-09 | 江苏威凌生化科技有限公司 | A kind of fluoroquinolones method in detection chicken |
CN107957456A (en) * | 2017-11-29 | 2018-04-24 | 王安波 | A kind of method of 4 kinds of fluo quinolone drug residuals in detection egg |
-
2019
- 2019-03-06 CN CN201910169867.2A patent/CN109946393B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN109946393A (en) | 2019-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fischer et al. | Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model4 | |
Chan et al. | Surveillance of nitrite level in cubilose: evaluation of removal method and proposed origin of contamination | |
CN101458238B (en) | Method for detecting Clenbuterol residual quantity in hair | |
DeGrasse et al. | Paralytic shellfish toxins in clinical matrices: extension of AOAC official method 2005.06 to human urine and serum and application to a 2007 case study in Maine | |
CN104897806B (en) | HPLC detection method for judging whether chrysanthemum has been sulfur-fumigated | |
Smith et al. | Analysis of volatile emissions from porcine faeces and urine using selected ion flow tube mass spectrometry | |
CN108445131B (en) | Method for detecting main components in edible betel nuts | |
Pelclová et al. | Leukotrienes B4, C4, D4 and E4 in the exhaled breath condensate (EBC), blood and urine in patients with pneumoconiosis | |
CN109946393B (en) | A kind of method for detecting ciprofloxacin residues in livestock and poultry | |
Suo et al. | Determination of ractopamine in animal hair: application to residue depletion in sheep and residue monitoring | |
Gbylik-Sikorska et al. | Determinaton of enrofloxacin and ciprofloxacin in albumin and freeze-dried-eggs by liquid chromatography with fluorescence detection | |
CN109060994B (en) | Method for detecting residual amount of ofloxacin in livestock and poultry hair | |
CN102495149B (en) | Determination method of residual crystal violet in crucian | |
Chang et al. | Simultaneous determination of eleven quinolones antibacterial residues in marine products and animal tissues by liquid chromatography with fluorescence detection | |
Zhang et al. | Residual detection of buparvaquone, nystatin, and etomidate in animal-derived food products in a single chromatographic run using liquid chromatography-tandem mass spectrometry | |
Červenka et al. | The relationship between the mercury concentration in fish muscles and scales/fins and its significance | |
CN103487539B (en) | Method for determining contents of albendazole and metabolites thereof in hemolymph of Bombyx mori by using ultra-fast liquid chromatography/triple-quadrupole tandem mass spectrometry (UFLC-MS/MS) | |
WO2020120376A1 (en) | In vitro method for detecting avian intestinal dysbiosis | |
CN114018886B (en) | Method for indirectly detecting sulfanilamide veterinary drug | |
CN107192767A (en) | The method that isotopic dilution gaschromatographic mass spectrometry determines eugenol in aquatic products | |
CN109738538A (en) | A method of identifying natural capping mature honey and thermally processed concentrated honey | |
CN103245715A (en) | Method for detecting clenbuterol hydrochloride in sample in assisted mode based on ion mobility spectrometry | |
CN109580818B (en) | Method for detecting florfenicol drug residue in pig hair | |
Dzieciol et al. | Methyl paraben as a sex pheromone in canine urine–is the question still open? | |
CN102778525A (en) | Detection method for residual quantity of salicylanilide veterinary drugs in animal-derived food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |